Serotonin signals through a gut-liver axis to regulate hepatic steatosis
No effective pharmacological treatments exist for nonalcoholic fatty liver disease (NAFLD). Here, the authors show that serotonin concentration in the portal blood is increased in nine human subjects and in mice fed a high-fat diet, and that local serotonin signaling ablation, either genetically or...
Guardado en:
Autores principales: | Wonsuk Choi, Jun Namkung, Inseon Hwang, Hyeongseok Kim, Ajin Lim, Hye Jung Park, Hye Won Lee, Kwang-Hyub Han, Seongyeol Park, Ji-Seon Jeong, Geul Bang, Young Hwan Kim, Vijay K. Yadav, Gerard Karsenty, Young Seok Ju, Chan Choi, Jae Myoung Suh, Jun Yong Park, Sangkyu Park, Hail Kim |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/89d5af7961f4435c8b79cd484b17891a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Publisher Correction: Serotonin signals through a gut-liver axis to regulate hepatic steatosis
por: Wonsuk Choi, et al.
Publicado: (2019) -
Preventive effect of Ligularia fischeri on inhibition of nitric oxide in lipopolysaccharide-stimulated RAW 264.7 macrophages depending on cooking method
por: Park,Hee-Sook, et al.
Publicado: (2014) -
Derivation and Evaluation of Satellite-Based Surface Current
por: Jun Myoung Choi, et al.
Publicado: (2021) -
Use of serotonin reuptake inhibitors and risk of subsequent bone loss in a nationwide population-based cohort study
por: Sunyoung Kang, et al.
Publicado: (2021) -
Trajectory patterns for continuous metabolic syndrome score in childhood and the cardiovascular risk in adolescence
por: Eun Jeong Choi, et al.
Publicado: (2021)